Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland

Virology Journal

Volumn 6, Issue , 2009, Pages

  Menton, John F ^a   Cremin, Suzanne M ^b   Canier, Lydie ^a   Horgan, Mary ^a,b   Fanning, Liam J ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b SOUTH INFIRMARY VICTORIA UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AMPLICON; ARTICLE; CONDYLOMA ACUMINATUM; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 6; IRELAND; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; VACCINATION; WART VIRUS; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PAPILLOMA VIRUS; PHYLOGENY; SEQUENCE HOMOLOGY; VIROLOGY; VIRUS INFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; CLUSTER ANALYSIS; CONDYLOMATA ACUMINATA; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HUMANS; IRELAND; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; SEQUENCE HOMOLOGY; SEXUALLY TRANSMITTED DISEASES, VIRAL; YOUNG ADULT;

EID: 69049087803     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-112     Document Type: Article

References (17)

1. Papillomavirus genome structure, expression, and post-transcriptional regulation. ZM Zheng CC Baker, Front Biosci 2006 11 2286 2302 16720315 10.2741/1971
2. Chapter 1: HPV in the etiology of human cancer. N Munoz X Castellsague AB de Gonzalez L Gissmann, Vaccine 2006 24 Suppl 3 S3/1 10
3. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. DR Brown JM Schroeder JT Bryan MH Stoler KH Fife, J Clin Microbiol 1999 37 3316 3322 10488198
4. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. JM Walboomers MV Jacobs MM Manos FX Bosch JA Kummer KV Shah PJ Snijders J Peto CJ Meijer N Munoz, J Pathol 1999 189 12 19 10.1002/(SICI)1096- 9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482
5. Classification of human papillomavirus. T Meyer E Stockfleth, N Engl J Med 2003 348 2040 2041 author reply 2040-2041. 10.1056/NEJM200305153482022 12748326
6. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. RP Insinga EJ Dasbach EH Elbasha, Pharmacoeconomics 2005 23 1107 1122 10.2165/00019053-200523110-00004 16277547
7. New approaches for the management of cervical cancer. TJ Herzog, Gynecol Oncol 2003 90 S22 27 10.1016/S0090-8258(03)00466-9 13129492
8. How will HPV vaccines affect cervical cancer? R Roden TC Wu, Nat Rev Cancer 2006 6 753 763 10.1038/nrc1973 16990853
9. Developing an HPV vaccine to prevent cervical cancer and genital warts. JT Bryan, Vaccine 2007 25 3001 3006 10.1016/j.vaccine.2007.01.013 17289220
10. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. DM Harper EL Franco CM Wheeler AB Moscicki B Romanowski CM Roteli-Martins D Jenkins A Schuind SA Costa Clemens G Dubin, Lancet 2006 367 1247 1255 10.1016/S0140-6736(06)68439-0 16631880
11. Improved amplification of genital human papillomaviruses. PE Gravitt CL Peyton TQ Alessi CM Wheeler F Coutlee A Hildesheim MH Schiffman DR Scott RJ Apple, J Clin Microbiol 2000 38 357 361 10618116
12. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. V Fontaine C Mascaux C Weyn A Bernis N Celio P Lefevre L Kaufman C Garbar, J Clin Microbiol 2007 45 928 934 17229855 10.1128/JCM.02098-06
13. Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger. T Matsukura M Sugase, Int J Gynecol Cancer 2008 18 1042 1050 10.1111/j.1525-1438.2007.01157.x 18248389
14. Prophylactic human papillomavirus vaccines. DR Lowy JT Schiller, J Clin Invest 2006 116 1167 1173 16670757 10.1172/JCI28607
15. Genital warts. N Dupin, Clin Dermatol 2004 22 481 486 10.1016/j.clindermatol.2004.07.003 15596319
16. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. EA Joura S Leodolter M Hernandez-Avila CM Wheeler G Perez LA Koutsky SM Garland DM Harper GW Tang DG Ferris et al, Lancet 2007 369 1693 1702 10.1016/S0140-6736(07) 60777-6 17512854
17. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Munoz FX Bosch S de Sanjose R Herrero X Castellsague KV Shah PJ Snijders CJ Meijer, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259